Skip to main content

BWAY · Brainsway Ltd. · Webcasts, Transcripts & Audio

Track BWAY — free
$12.60 -0.60 (-4.55%)
Market Cap
$542.61M
Shares
40.25M
Volume · Oct 1 137.95K Avg daily vol (3M) 115.56K

Brainsway Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for Brainsway Ltd. (BWAY), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-10-17
Brainsway Ltd. (BWAY) October 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-26
Brainsway Ltd. (BWAY) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-25
Brainsway Ltd. (BWAY) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-12
Brainsway Ltd. (BWAY) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Brainsway Ltd. (BWAY) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Brainsway Ltd. (BWAY) Q4 2025 Earnings Call Transcript
Confident tone Neurolief / ProlivRx partnership Clinical pipeline and FDA submissions Recurring revenue model and RPO
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Brainsway Ltd. (BWAY) Q3 2025 Earnings Call Transcript
Confident tone Accelerated FDA protocol and clinical pipeline Deep TMS system shipments and installed base Revenue growth and guidance raise
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Brainsway Ltd. (BWAY) Q2 2025 Earnings Call Transcript
Confident tone Clinical evidence and regulatory indications Next-gen TMS 360 platform and new indications Recurring revenue and multiyear lease model
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Brainsway Ltd. (BWAY) Q1 2025 Earnings Call Transcript
Confident tone Revenue Growth & Shipments Accelerated MDD Protocol / R&D OCD Indication
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Brainsway Ltd. (BWAY) Q4 2024 Earnings Call Transcript
Confident tone Profitability and Cash Generation Revenue Growth and Shipments Depression/Anxious Depression/Elderly MDD
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Brainsway Ltd. (BWAY) Q3 2024 Earnings Call Transcript
Confident tone Revenue growth and guidance Deep TMS system and next-generation platform International expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Brainsway Ltd. (BWAY) Q2 2024 Earnings Call Transcript
Confident tone International expansion FDA label expansion for MDD in elderly Revenue growth and guidance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Brainsway Ltd. (BWAY) Q1 2024 Earnings Call Transcript
Confident tone Revenue Growth and Financial Performance Clinical Evidence and R&D Pipeline Deep TMS Installed Base and System Shipments
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Brainsway Ltd. (BWAY) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–14 of 14 webcasts
Key facts CIK 1505065 CUSIP 10501L106 13F (30d) 1 filings 1 filers Visit website Investor relations